Department of Health and Human Services

Modernizing the Human Subjects Regulations

Given its importance in scientific development, human subjects research requires close regulatory attention.

Prescription Drug Affordability

The court ruling striking down the Affordable Care Act may get in the way of making drugs affordable.

Addressing the Constitutionality of Federal Quarantine Rules

Scholars say constitutionally shaky infectious disease regulations must yield to better prevention programs.

Should the Federal Government Allow States to Require Medicaid Recipients to Work?

A federal judge strikes a blow to two states’ Medicaid work requirements.

Judge Suspends Rules Expanding Exemptions to the Contraceptive Mandate

National injunction stops corporations from claiming religious or moral exemptions to birth control coverage.

Increasing Vaccination Rates Without Eliminating Nonmedical Exemptions

States should shift incentives to reduce nonmedical exemptions while respecting the choice not to vaccinate.

Can the Law Accommodate Recognizing Nonbinary Individuals?

Scholar urges new regulatory frameworks for recognizing nonbinary individuals under the law.

New Approach to Affordable Care Act Waivers Causes Controversy

The Trump Administration encourages states to use “innovation waivers” to find new ways to lower costs.

Preserving Clinician Discretion Under Health Privacy Regulation

HIPAA does not stop health care providers from disclosing patient information to provide better care.

Proposed Rule Aims to Make Drug Pricing More Transparent

A proposed requirement to display drug list prices in advertisements draws controversy.

Deregulatory Realities and Illusions

President Trump’s claims that deregulation has greatly helped the economy are exaggerated.

How to Better Regulate Payments to Research Participants

Experts say federal agencies must clarify rules permitting payment to research subjects.